The causes of skin cancer involve a variety of complex biological mechanisms and environmental interactions. Research shows that over 90% of skin cancer cases are related to ultraviolet exposure, genetic mutations, and specific environmental exposures. These factors damage the DNA structure of skin cells, leading to uncontrolled cell division and ultimately forming malignant tumors.
The development of skin cancer typically involves a multi-stage carcinogenic process: initial genetic mutations may only cause cellular dysfunction, but long-term accumulated damage can lead to failure of cellular repair mechanisms. Environmental factors and genetic susceptibility often work together; for example, patients with hereditary DNA repair defects have a cancer risk that is several times higher than the general population after exposure to ultraviolet light.
Modern medicine has identified risk factors that can be categorized into congenital and acquired types. Genetic vulnerabilities, a history of prolonged ultraviolet exposure, and exposure to chemicals all increase the incidence of skin cancer. The following sections will explore the specific mechanisms and clinical observations of various risk factors.
Abnormalities in genetic material are significant intrinsic factors in the development of skin cancer. Specific gene mutations such as CDKN2A and TP53 weaken the apoptotic mechanisms, leading to the inability to properly repair damaged DNA. If multiple first-degree relatives in a family have melanoma, the risk for descendants may be 5 to 8 times higher than that of the general population.
Hereditary syndromes such as Xeroderma Pigmentosum severely affect the ultraviolet repair system, with patients developing skin cancer an average of 20 years earlier, and cases of multiple site involvement are more common. This genetic defect prevents DNA repair enzymes from functioning normally, resulting in the inability to remove ultraviolet-induced pyrimidine dimers.
Ultraviolet radiation is the most critical environmental factor leading to skin cancer. The UVB range (290-320 nm) of solar ultraviolet light directly induces chemical bond mutations in DNA, while UVA (320-400 nm) damages cell membrane structures through oxidative stress. Prolonged exposure in environments with a UV index exceeding 10 exponentially increases the cumulative risk of skin cancer.
Chemical carcinogens in the environment also play an important role. Exposure to aromatic amines such as coal tar, or long-term contact with pesticides and herbicides in agricultural settings, are classified as Group 1 carcinogens by the International Agency for Research on Cancer (IARC). Miners exposed to arsenic compounds have a skin cancer risk that is 3-5 times higher than that of the general population.
The impact of geographic environment cannot be ignored. Residents near the polar regions experience enhanced ultraviolet exposure due to ozone layer depletion, resulting in a relatively higher incidence of skin cancer. The intensity of ultraviolet light in high-altitude areas increases by 4% for every 300 meters above sea level, posing additional risks to mountain residents.
Improper sun exposure behaviors are modifiable high-risk factors. Studies show that a history of a single sunburn increases the risk of melanoma by 80%, while cumulative sun exposure time is negatively correlated with the age of diagnosis for basal cell carcinoma. Teenagers who use tanning beds have a 75% higher incidence of skin cancer compared to their peers.
Tobacco use is directly associated with the malignant transformation of actinic keratosis (sun-induced keratosis). Nicotine metabolites in the skin of smokers suppress T-cell activity, while nicotine induces excessive expression of the COX-2 enzyme, promoting tumor angiogenesis. Long-term smokers have a 2.3 times increased risk of non-melanoma skin cancer.
Immunosuppressed states also exacerbate cancer risk. Organ transplant patients, due to long-term use of immunosuppressants, have a skin cancer incidence that is 200 times that of the general population. HIV-infected individuals have severely impaired surveillance of early tumor cells due to insufficient T-cell counts.
Age is positively correlated with the risk of skin cancer, with tumor malignant transformation occurring 3 times faster in patients over 65 than in younger patients. This is related to long-term accumulated DNA damage, telomere depletion, and degradation of cellular repair mechanisms.
Skin type is closely related to natural defense capabilities. Individuals classified as Fitzpatrick Type I (fair skin, prone to sunburn) have a melanoma risk that is 40 times higher than those classified as Type V (dark skin). A lower melanin content on the skin surface reduces the natural ability to absorb ultraviolet light.
Chronic wounds and repeatedly damaged areas are prone to precancerous lesions. Long-term exposure to friction, burns, or radiation therapy can induce malignant transformation due to abnormal cellular repair processes. Patients with a history of radiation therapy have a 2-6 times higher risk of skin cancer in the treatment area after 10 years.
In summary, the formation of skin cancer is the result of multifactorial interactions. Genetic susceptibility provides an internal risk basis, while environmental and behavioral factors accelerate the carcinogenic process. Environmental ultraviolet exposure and contact with chemical carcinogens, combined with insufficient personal protective measures, constitute the primary pathogenic network for skin cancer in modern society. Understanding these causes helps in formulating targeted prevention strategies, such as increasing the frequency of skin checks for genetically at-risk populations and establishing public sun protection guidelines in high ultraviolet areas.
When selecting sunscreen products, prioritize those with high SPF (recommended above 30) and PA++++ (to prevent UVA), and check if the ingredients include physical sunscreens (such as zinc oxide, titanium dioxide) or chemical sunscreen components. Additionally, it is recommended to reapply every two hours when outdoors, even on cloudy days or when indoors near windows, to fully block ultraviolet damage to the skin.
What should I do if I notice changes in a mole on my skin?If a mole suddenly changes in size, shape, or color, or if symptoms such as itching or bleeding occur, seek medical attention immediately for a dermatoscopic examination or biopsy. According to the "ABCDE rule," if the mole has irregular borders, uneven color, or a diameter greater than 6 millimeters, these are also high-risk signs that require professional evaluation to determine if it is melanoma or other malignant changes.
Are individuals with weakened immune systems more susceptible to skin cancer?Yes. An impaired immune system (such as those taking immunosuppressants after organ transplantation, HIV-infected individuals, or patients with autoimmune diseases) reduces the body's ability to monitor abnormal cells, increasing the risk of skin cancer, particularly basal cell carcinoma and squamous cell carcinoma. Such patients should enhance their daily sun protection measures and undergo professional skin examinations every six months.
What preventive measures should individuals with a family history of skin cancer take?Those with a family history should not only strictly adhere to daily sun protection but also have annual full-body skin examinations by a dermatologist and keep track of changes in skin spots. Additionally, they should avoid sunbathing or using tanning beds, and wear wide-brimmed hats, long-sleeved clothing, and UV-protective sunglasses during outdoor activities to reduce the risk of cumulative ultraviolet exposure.
Are early symptoms of skin cancer easily confused with common skin issues?Yes. For example, early melanoma may appear as a regular mole or sunburn mark, but features such as blurred borders and mixed colors (black, brown, red, blue) should be particularly noted. If the skin shows persistent but non-itchy patches that gradually enlarge, or ulcers that do not heal, seek medical attention promptly for differential diagnosis to avoid misdiagnosis with common dermatitis or eczema, which could delay treatment.
%201.svg)
Copyright © 2025 MedFrontiers. All Rights Reserved.
